Figure 3.
Dopamine content in nucleus accumbens and dorsal striatum of BDNF2L/2LCk-cre mutant mice. A, HPLC measurements of DA and DOPAC content and DOPAC/DA ratios in the nucleus accumbens of wild-type control (WT) and BDNF2L/2LCk-cre conditional mutant (CM) mice (n = 5; *p = 0.02). B, Dopamine and DOPAC content and DOPAC/DA ratios in the dorsal striatum of wild-type control and BDNF2L/2LCk-cre conditional mutant mice (n = 5; *p = 0.002; **p = 0.007).